BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial

BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial

Abstract Acellular pertussis (aP) booster vaccines are central to pertussis immunization programs, although their effectiveness varies. The Bacille Calmette-Guérin (BCG) vaccine is a prototype inducer of trained immunity, which enhances immune responses to subsequent infections or vaccinations. Whil...

Full description

Bibliographic Details
Main Authors:	Joshua Gillard, Bastiaan A. Blok, Daniel R. Garza, Prashanna Balaji Venkatasubramanian, Elles Simonetti, Marc J. Eleveld, Guy A. M. Berbers, Pieter G. M. van Gageldonk, Irma Joosten, Ronald de Groot, L. Charlotte J. de Bree, Reinout van Crevel, Marien I. de Jonge, Martijn A. Huynen, Mihai G. Netea, Dimitri A. Diavatopoulos
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-02-01
Series:	npj Vaccines
Online Access:	https://doi.org/10.1038/s41541-022-00438-4

Similar Items

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
by: Evi van Schuppen, et al.
Published: (2022-12-01)

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis
by: Joshua Gillard, et al.
Published: (2024-03-01)

Uncovering Distinct Primary Vaccination-Dependent Profiles in Human <i>Bordetella pertussis</i> Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay
by: Eleonora E. Lambert, et al.
Published: (2020-05-01)

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups
by: Aapo Knuutila, et al.
Published: (2022-12-01)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
by: Pauline Versteegen, et al.
Published: (2021-06-01)

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis
by: Gillard, J, et al.
Published: (2024)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
by: Saskia van der Lee, et al.
Published: (2018-04-01)

Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site.
by: Anne Zeddeman, et al.
Published: (2020-01-01)

Innate Immune Recognition of Mycobacterium tuberculosis
by: Johanneke Kleinnijenhuis, et al.
Published: (2011-01-01)

Lack of Cell Cycle Inhibitor p21 and Low CD4+ T Cell Suppression in Newborns After Exposure to IFN-β
by: Jop Jans, et al.
Published: (2021-04-01)

Proteomics-identified Bvg-activated autotransporters protect against bordetella pertussis in a mouse model.
by: Daan de Gouw, et al.
Published: (2014-01-01)

Acellular Pertussis Vaccines Have Arrived
by: Scott A Halperin
Published: (1996-01-01)

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
by: Aapo Knuutila, et al.
Published: (2023-12-01)

Acellular versus Whole-Cell Pertussis Vaccines
by: S Halperin, et al.
Published: (1992-01-01)

Acellular Pertussis Vaccine Components: Today and Tomorrow
by: Kalyan K. Dewan, et al.
Published: (2020-05-01)

The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis.
by: Ekta Lachmandas, et al.
Published: (2015-01-01)

Designing the Next Generation of Vaccines: Relevance for Future Pandemics
by: Jorge Domínguez-Andrés, et al.
Published: (2020-12-01)

Should acellular pertussis vaccine be recommended to healthcare professionals?
by: José Cassio de Moraes, et al.
Published: (2013-07-01)

Should acellular pertussis vaccine be recommended to healthcare professionals?
by: José Cassio de Moraes, et al.

SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
by: Janeri Fröberg, et al.
Published: (2021-09-01)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
by: Clara Maria Ausiello, et al.
Published: (2014-07-01)

Vacina acelular contra pertússis para adolescentes Acellular pertussis vaccine for adolescents
by: Aroldo P. de Carvalho, et al.
Published: (2006-07-01)

A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses
by: Véronique Corbière, et al.
Published: (2023-02-01)

The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice
by: Reinout van Crevel, et al.
Published: (2021-01-01)

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.
by: Sabine C de Greeff, et al.
Published: (2010-01-01)

Comparative analysis of whole-cell and acellular pertussis vaccines efficacy in preventing pertussis
by: I. A. Alekseeva, et al.
Published: (2018-02-01)

A novel flow cytometry-based assay for the quantification of antibody-dependent pneumococcal agglutination.
by: Marrit N Habets, et al.
Published: (2017-01-01)

Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age.
by: Rose-Minke Schure, et al.
Published: (2012-01-01)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
by: Kevin Markey, et al.
Published: (2019-07-01)

The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins
by: Daan de Gouw, et al.
Published: (2014-01-01)

Umbilical cord-mesenchymal stem cells induce a memory phenotype in CD4+ T cells
by: Ezgi Sengun, et al.
Published: (2023-06-01)

SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patients
by: Lisa Kurver, et al.
Published: (2022-05-01)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
by: Aapo Knuutila, et al.
Published: (2023-12-01)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
by: Susanna Esposito, et al.
Published: (2019-07-01)

Severe osteoarticular and skin and soft tissue infection with Mycobacterium bovis following intravesical BCG instillation
by: Anniek Strijdhorst, et al.
Published: (2024-04-01)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
by: Jens Möller, et al.
Published: (2019-06-01)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008-01-01)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008-01-01)

The influence of the gut microbiome on BCG-induced trained immunity
by: Stražar, Martin, et al.
Published: (2022)

The influence of the gut microbiome on BCG-induced trained immunity
by: Stražar, Martin, et al.
Published: (2021)